Michael A. Panzara Insider Trading $WVE Wave Life Sciences Ltd.
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for Michael A. Panzara.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of Michael A. Panzara. Michael A. Panzara is Chief Medical Officer in Wave Life Sciences Ltd. ($WVE) and Franchise Lead, Neurology in Wave Life Sciences Ltd. ($WVE) and Head of Neurology Franchise in Wave Life Sciences Ltd. ($WVE) and See Remarks in Wave Life Sciences Ltd. ($WVE).
Michael A. Panzara in Wave Life Sciences Ltd.
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of Michael A. Panzara: See Remarks, Chief Medical Officer, Head of Neurology Franchise, Franchise Lead, Neurology
Holdings: 89,349 shares
Current Value: $2,577,719
Latest Transaction: Feb 18 2021
$WVE Market Capitalization: $681.95M
$WVE Previous Close: $28.85
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD
Latest Insider Trading Transactions of Michael A. Panzara in Wave Life Sciences Ltd.
| 1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
|---|---|---|---|---|---|---|---|
| No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Page: 1
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Feb 18 2021 | WVE | Wave Life Sciences ... | Panzara Michael A. | See Remarks | Option Exercise | A | 10.48 | 50,000 | 524,000 | 50,000 | |
| Feb 18 2021 | WVE | Wave Life Sciences ... | Panzara Michael A. | See Remarks | Sell | S | 10.57 | 2,929 | 30,960 | 86,420 | 89.3 K to 86.4 K (-3.28 %) |
| Feb 18 2021 | WVE | Wave Life Sciences ... | Panzara Michael A. | See Remarks | Grant | A | 0.00 | 50,000 | 0 | 89,349 | 39.3 K to 89.3 K (+127.07 %) |
| Mar 05 2020 | WVE | Wave Life Sciences ... | Panzara Michael A. | Chief Medical Offic ... | Option Exercise | A | 8.17 | 36,000 | 294,120 | 36,000 | |
| Feb 20 2020 | WVE | Wave Life Sciences ... | Panzara Michael A. | Chief Medical Offic ... | Sell | S | 7.85 | 2,981 | 23,401 | 39,349 | 42.3 K to 39.3 K (-7.04 %) |
| Jul 09 2019 | WVE | Wave Life Sciences ... | Panzara Michael A. | Chief Medical Offic ... | Sell | S | 27.26 | 445 | 12,131 | 42,330 | 42.8 K to 42.3 K (-1.04 %) |
| Jul 09 2019 | WVE | Wave Life Sciences ... | Panzara Michael A. | Chief Medical Offic ... | Sell | S | 26.88 | 2,613 | 70,237 | 42,775 | 45.4 K to 42.8 K (-5.76 %) |
| Mar 11 2019 | WVE | Wave Life Sciences ... | Panzara Michael A. | Franchise Lead, Neu ... | Sell | S | 48.00 | 7,000 | 336,000 | 45,388 | 52.4 K to 45.4 K (-13.36 %) |
| Mar 11 2019 | WVE | Wave Life Sciences ... | Panzara Michael A. | Franchise Lead, Neu ... | Grant | A | 0.00 | 15,000 | 0 | 52,388 | 37.4 K to 52.4 K (+40.12 %) |
| Feb 21 2019 | WVE | Wave Life Sciences ... | Panzara Michael A. | Franchise Lead, Neu ... | Sell | S | 36.84 | 1,837 | 67,674 | 37,388 | 39.2 K to 37.4 K (-4.68 %) |
| Feb 21 2018 | WVE | Wave Life Sciences ... | Panzara Michael A. | Franchise Lead, Neu ... | Sell | S | 52.10 | 511 | 26,623 | 39,225 | 39.7 K to 39.2 K (-1.29 %) |
| Feb 20 2018 | WVE | Wave Life Sciences ... | Panzara Michael A. | Franchise Lead, Neu ... | Option Exercise | M | 21.69 | 18,750 | 406,688 | 131,250 | |
| Feb 20 2018 | WVE | Wave Life Sciences ... | Panzara Michael A. | Franchise Lead, Neu ... | Sell | S | 50.00 | 18,750 | 937,500 | 39,736 | 58.5 K to 39.7 K (-32.06 %) |
| Feb 20 2018 | WVE | Wave Life Sciences ... | Panzara Michael A. | Franchise Lead, Neu ... | Buy | M | 21.69 | 18,750 | 406,688 | 58,486 | 39.7 K to 58.5 K (+47.19 %) |
| Jan 25 2018 | WVE | Wave Life Sciences ... | Panzara Michael A. | Franchise Lead, Neu ... | Option Exercise | A | 40.05 | 35,000 | 1,401,750 | 35,000 | |
| Jan 25 2018 | WVE | Wave Life Sciences ... | Panzara Michael A. | Franchise Lead, Neu ... | Grant | A | 0.00 | 17,500 | 0 | 39,736 | 22.2 K to 39.7 K (+78.70 %) |
| Jul 13 2017 | WVE | WAVE Life Sciences ... | Panzara Michael A. | Franchise Lead, Neu ... | Sell | S | 16.67 | 7,414 | 123,620 | 15,336 | 22.8 K to 15.3 K (-32.59 %) |
| Jan 27 2017 | WVE | Wave Life Sciences ... | Panzara Michael A. | Head of Neurology F ... | Option Exercise | A | 29.05 | 13,800 | 400,890 | 13,800 | |
| Jan 27 2017 | WVE | Wave Life Sciences ... | Panzara Michael A. | Head of Neurology F ... | Grant | A | 0.00 | 6,900 | 0 | 29,650 | 22.8 K to 29.7 K (+30.33 %) |
| Jul 13 2016 | WVE | Wave Life Sciences ... | Panzara Michael A. | Franchise Lead, Neu ... | Option Exercise | A | 21.69 | 150,000 | 3,253,500 | 150,000 | |
| Jul 13 2016 | WVE | Wave Life Sciences ... | Panzara Michael A. | Franchise Lead, Neu ... | Grant | A | 0.00 | 22,750 | 0 | 22,750 | 0 to 22.8 K |
Page: 1